SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-029145
Filing Date
2023-06-21
Accepted
2023-06-21 16:05:47
Documents
12
Period of Report
2023-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K hsto-20230620.htm   iXBRL 8-K 65110
  Complete submission text file 0000950170-23-029145.txt   189744

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hsto-20230620_lab.xml EX-101.LAB 17781
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hsto-20230620_pre.xml EX-101.PRE 11118
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hsto-20230620.xsd EX-101.SCH 2474
6 EXTRACTED XBRL INSTANCE DOCUMENT hsto-20230620_htm.xml XML 4699
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 231029856
SIC: 2834 Pharmaceutical Preparations